摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-异丙基-2-硫脲 | 1719-76-2

中文名称
1-异丙基-2-硫脲
中文别名
异丙基硫脲;N-异丙基硫脲
英文名称
1-isopropylthiourea
英文别名
N-Isopropyl-thioharnstoff;isopropylthiourea;N-isopropylthiourea;Isopropylthioharnstoff;1-isopropyl-2-thiourea;Urea, 1-isopropyl-2-thio-;propan-2-ylthiourea
1-异丙基-2-硫脲化学式
CAS
1719-76-2
化学式
C4H10N2S
mdl
MFCD00041375
分子量
118.203
InChiKey
POXAIQSXNOEQGM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    169-170°C
  • 沸点:
    173.8±23.0 °C(Predicted)
  • 密度:
    1.051±0.06 g/cm3(Predicted)
  • 稳定性/保质期:
    在常温常压下保持稳定,应避免与氧化物接触。

计算性质

  • 辛醇/水分配系数(LogP):
    0.4
  • 重原子数:
    7
  • 可旋转键数:
    1
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    70.1
  • 氢给体数:
    2
  • 氢受体数:
    1

安全信息

  • 安全说明:
    S22,S36/37/39
  • 危险类别码:
    R22
  • 危险品运输编号:
    2811
  • RTECS号:
    YT6125000
  • 海关编码:
    2930909090
  • 包装等级:
    III
  • 危险类别:
    6.1
  • 危险性防范说明:
    P501,P270,P264,P301+P310+P330,P405
  • 危险性描述:
    H301
  • 储存条件:
    请将容器密封保存,并存放在阴凉、干燥的地方。

SDS

SDS:5d2cb0ab848458caf06774f94a750088
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: N-Isopropylthiourea
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H302: Harmful if swallowed
P308+P313: IF exposed or concerned: Get medical advice/attention
P330: Rinse mouth

Section 3. Composition/information on ingredients.
Ingredient name: N-Isopropylthiourea
CAS number: 1719-76-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C4H10N2S
Molecular weight: 118.2

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-异丙基-2-硫脲sodium chlorite二氯甲烷 、 sodium carbonate 作用下, 生成 isopropylcyanamide
    参考文献:
    名称:
    DE1018858
    摘要:
    公开号:
  • 作为产物:
    描述:
    参考文献:
    名称:
    取代5,5'-二苯基-2-硫代咪唑啉酮-4-酮作为CB1大麻素受体配体:合成和药理学评估。
    摘要:
    合成了一组30个取代的5,5'-二苯基-2-硫代氧杂咪唑啉-4-酮(硫代乙内酰脲)衍生物,并评估了它们对人CB(1)大麻素受体的亲和力。这些化合物衍生自先前描述的大麻素配体5,5'-二苯基咪唑烷-2,4-二酮(乙内酰脲)。用硫取代氧会导致亲和力增加,而[[35] S] GTPgammaS实验所确定的功能(即反向激动作用)仍然不受影响。最后,为了评估可能影响巯基乙内酰脲亲和力的分子参数,对代表性的巯基乙内酰脲和乙内酰脲衍生物进行了分子静电势以及亲脂性计算。总之,5,5'-双-(4-碘苯基)-3-丁基-2-硫代氧杂咪唑啉丁-4-酮(31)和3-烯丙基-5,
    DOI:
    10.1021/jm049263k
点击查看最新优质反应信息

文献信息

  • 一种抗菌增效剂及其制法和用途
    申请人:上海医药工业研究院
    公开号:CN107629022A
    公开(公告)日:2018-01-26
    本发明涉及一种抗菌增效剂及其制法和用途。具体地,本发明公开了式(I)所示的具有抗菌增效活性的化合物或其光学异构体、顺反异构体或医药学上可接受的盐,及其制备方法。本发明还公开了包含上述化合物的医用组合物及其用途。上述化合物可有效增强多粘菌素B对鲍曼不动杆菌与肺炎克雷伯菌的抗菌活性,并可应用于对多粘菌素不敏感或抑菌活性不强的病菌的抗菌治疗。
  • [EN] HEPATITIS C VIRUS INHIBITORS<br/>[FR] INHIBITEURS DU VIRUS DE L'HEPATITE C
    申请人:BRISTOL MYERS SQUIBB CO
    公开号:WO2003099274A1
    公开(公告)日:2003-12-04
    Hepatitis C virus inhibitors are disclosed having the general formula:(I) wherein R1, R2, R3, R', B, Y and X are described in the description. Compositions comprising the compounds and methods for using the compounds toinhibit HCV are also disclosed.
    丙型肝炎病毒抑制剂公开了具有以下通式:其中R1、R2、R3、R'、B、Y和X在描述中有所描述。还公开了包含该化合物的组合物以及使用该化合物抑制HCV的方法。
  • [EN] A COLORANT COMPOUND, AND A COLORANT MATERIAL COMPRISING THE SAME<br/>[FR] COMPOSÉ DE COLORANT, ET MATIÈRE DE COLORANT LE COMPRENANT
    申请人:IRIDOS LTD
    公开号:WO2017114742A1
    公开(公告)日:2017-07-06
    A disclosure of the present invention includes novel colorant compounds based on triarylmethane structure, methods for preparing the same, and colorant materials comprising the same.
    本发明的公开包括基于三芳基甲烷结构的新型着色剂化合物、制备该化合物的方法以及包含该化合物的着色材料。
  • Macrocylic Inhibitors of Hepatitis C Virus
    申请人:Simmen Kenneth Alan
    公开号:US20090118312A1
    公开(公告)日:2009-05-07
    Compounds of the formula I: and N-oxides, salts, and stereoisomers thereof wherein A is OR 1 , NHS(═O) p R 2 ; wherein; R 1 is hydrogen, C 1 -C 6 alkyl, C 0 -C 3 alkylenecarbocyclyl, C 0 -C 3 alkylene-heterocyclyl; R 2 is C 1 -C 6 alkyl, C 0 -C 3 alkylenecarbocyclyl, C 0 -C 3 alkyleneheterocyclyl; p is independently 1 or 2; n is 3, 4, 5 or 6; — denotes an optional double bond; L is N or CRz; Rz is H or forms a double bond with the asterisked carbon; Rq is H or when L is CRz, Rq can also be C 1 -C 6 alkyl; Rr is quinazolinyl, optionally substituted with one two or three substituents each independently selected from C 1 -C 6 alkyl, C 1 -C 6 alkoxy, hydroxyl, halo, haloC 1 -C 6 alkyl, amino, mono- or dialkylamino, mono- or dialkylaminocarbonyl, C 1 -C 6 alkyl-carbonylamino, C 0 -C 3 alkylenecarbocyclyl and C 0 -C 3 alkyleneheterocyclyl; R 5 is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxyC 1 -C 6 alkyl or C 3 -C 7 cycloalkyl; R 6 is hydrogen, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, C 0 -C 3 alkylenecarbocyclyl, C 0 -C 3 alkylene-heterocyclyl, hydroxy, bromo, chloro or fluoro have utility in the treatment or prophylaxis of flaviviral infections such as HCV
    公式I的化合物: 以及其N-氧化物、盐和立体异构体 其中 A是OR 1 ,NHS(═O) p R 2 ;其中; R 1 是氢、C 1 -C 6 烷基、C 0 -C 3 烷基烯基环烷基、C 0 -C 3 烷基烯基杂环烷基; R 2 是C 1 -C 6 烷基、C 0 -C 3 烷基烯基环烷基、C 0 -C 3 烷基烯基杂环烷基; p独立地为1或2; n为3、4、5或6;— 表示一个可选的双键; L是N或CRz; Rz是H或与带星号的碳形成双键; Rq是H或当L为CRz时,Rq也可以是C 1 -C 6 烷基; Rr是喹唑啉基,可选择地取代一个、两个或三个取代基,每个取代基独立地选自C 1 -C 6 烷基、C 1 -C 6 烷氧基、羟基、卤素、卤代C 1 -C 6 烷基、氨基、单烷基或二烷基氨基、单烷基或二烷基氨基甲酰基、C 1 -C 6 烷基-甲酰氨基、C 0 -C 3 烷基烯基环烷基和C 0 -C 3 烷基烯基杂环烷基; R 5 是氢、C 1 -C 6 烷基、C 1 -C 6 烷氧基C 1 -C 6 烷基或C 3 -C 7 环烷基; R 6 是氢、C 1 -C 6 烷基、C 1 -C 6 烷氧基、C 0 -C 3 烷基烯基环烷基、C 0 -C 3 烷基烯基杂环烷基、羟基、溴、氯或氟在治疗或预防黄病毒感染如HCV中具有用途
  • Macrocyclic Inhibitors of Hepatitis C Virus
    申请人:Wahling Horst
    公开号:US20090023758A1
    公开(公告)日:2009-01-22
    Compounds of the formula (I): and N-oxides, salts and stereoisomers thereof wherein A is OR 1 , NHS(═O) p R 2 , NHR 3 , NRaRb, C(═O)NHR 3 or C(═O)NRaRb wherein; R 1 is hydrogen, C 1 -C 6 alkyl, C 0 -C 3 alkylenecarbocyclyl, C 0 -C 3 alkyleneheterocyclyl; R 2 is C 1 -C 6 alkyl, C 0 -C 3 alkylenecarbocyclyl, C 0 -C 3 alkyleneheterocyclyl or NRaRb; R 3 is C 1 -C 6 alkyl, C 0 -C 3 alkylenecarbocyclyl, C 0 -C 3 alkyleneheterocyclyl, —OC 1 -C 6 alkyl, —OC 0 -C 3 alkylenecarbocyclyl, —OC 0 -C 3 alkyleneheterocyclyl; wherein any alkyl, carbocyclyl or heterocycylyl in R 1 , R 2 or R 3 are optionally substituted p is independently 1 or 2; n is 3, 4, 5 or 6; denotes an optional double bond; Rq is H or when L is CRz, Rq can also be C 1 -C 6 alkyl; Ry and Ry′ are independently C 1 -C 6 alkyl; L is N or CRz; Rz is H or forms a double bond with the asterisked carbon; W is —CH 2 —, —O—, —OC(═O)NH—, —OC(═O)—, —S—, —NH—, —NRa, —NHS(═O) 2 —, —NHC(=0)NH— or —NHC(═O)—, —NHC(═S)NH— or a bond; R 8 is an optionally substituted ring system containing 1 or 2 saturated, partially saturated or unsaturated carbo or heterocyclic rings have utility in the inhibition of NS-3 serine proteases, such as flavivirus infections.
    式(I)的化合物:及其N-氧化物、盐和立体异构体,其中A为OR1、NHS(═O)pR2、NHR3、NRaRb、C(═O)NHR3或C(═O)NRaRb,其中;R1为氢、C1-C6烷基、C0-C3烷基环戊基、C0-C3烷基杂环戊基;R2为C1-C6烷基、C0-C3烷基环戊基、C0-C3烷基杂环戊基或NRaRb;R3为C1-C6烷基、C0-C3烷基环戊基、C0-C3烷基杂环戊基、—OC1-C6烷基、—OC0-C3烷基环戊基、—OC0-C3烷基杂环戊基;其中R1、R2或R3中的任何烷基、环戊基或杂环戊基可选择性地被取代;p独立地为1或2;n为3、4、5或6;表示可选的双键;Rq为H或当L为CRz时,Rq也可以是C1-C6烷基;Ry和Ry′独立地为C1-C6烷基;L为N或CRz;Rz为H或与带星号的碳形成双键;W为—CH2—、—O—、—OC(═O)NH—、—OC(═O)—、—S—、—NH—、—NRa、—NHS(═O)2—、—NHC(=0)NH—或—NHC(═O)—、—NHC(═S)NH—或键;R8为含有1或2个饱和、部分饱和或不饱和碳或杂环环的可选择性取代的环系统,在NS-3丝氨酸蛋白酶的抑制中具有用途,例如黄病毒感染。
查看更多